These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17599739)

  • 61. Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice.
    Jin JO; Kawai T; Cha S; Yu Q
    Arthritis Rheum; 2013 Aug; 65(8):2132-42. PubMed ID: 23666710
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndrome.
    Egerer T; Martinez-Gamboa L; Dankof A; Stuhlmüller B; Dörner T; Krenn V; Egerer K; Rudolph PE; Burmester GR; Feist E
    Arthritis Rheum; 2006 May; 54(5):1501-8. PubMed ID: 16646031
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
    Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
    J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The possible etiopathogenic genes of Sjögren's syndrome.
    Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
    Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.
    Nanni JM; Nguyen KH; Alford CE; Robinson CP; Stewart CM; Maeda N; Humphreys-Beher MG
    Clin Exp Rheumatol; 1997; 15(5):515-21. PubMed ID: 9307859
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sjögren's syndrome.
    Rhodus NL
    Quintessence Int; 1999 Oct; 30(10):689-99. PubMed ID: 10765853
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
    Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
    Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome.
    Vosters JL; Yin H; Roescher N; Kok MR; Tak PP; Chiorini JA
    Arthritis Res Ther; 2009; 11(6):R189. PubMed ID: 20003451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
    Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
    Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
    Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
    Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome.
    Takada K; Takiguchi M; Konno A; Inaba M
    Rheumatology (Oxford); 2004 Jul; 43(7):858-62. PubMed ID: 15126673
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
    Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
    Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Injection of CD40 DNA vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with Sjögren's syndrome.
    Zhou YB; Yuan X; Wang QK; Zhang H; Wang GS; Li XP; Wang Y; Harris D; Li XM
    Immunol Lett; 2020 Oct; 226():62-70. PubMed ID: 32707129
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjögren's syndrome.
    Tsubata R; Tsubata T; Hiai H; Shinkura R; Matsumura R; Sumida T; Miyawaki S; Ishida H; Kumagai S; Nakao K; Honjo T
    Eur J Immunol; 1996 Nov; 26(11):2742-8. PubMed ID: 8921964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Investigations of various animal models for Sjögren's syndrome].
    Hayashi Y
    Nihon Rinsho; 1995 Oct; 53(10):2383-8. PubMed ID: 8531342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
    Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
    Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sjögren's syndrome: a condition with features of chronic graft-versus-host disease: does duct cell adhesion or permeability play a role in pathogenesis?
    Lamey PJ; Lundy FT; Al-Hashimi I
    Med Hypotheses; 2004; 62(5):825-9. PubMed ID: 15082115
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice.
    Rosignoli F; Goren NB; Pérez Leirós C
    Clin Immunol; 2001 Oct; 101(1):86-93. PubMed ID: 11580230
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.
    Green JE; Hinrichs SH; Vogel J; Jay G
    Nature; 1989 Sep; 341(6237):72-4. PubMed ID: 2788824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome.
    Brayer JB; Cha S; Nagashima H; Yasunari U; Lindberg A; Diggs S; Martinez J; Goa J; Humphreys-Beher MG; Peck AB
    Scand J Immunol; 2001; 54(1-2):133-40. PubMed ID: 11439159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.